BioCeramic Therapeutics appoints new CEO
This article was originally published in Clinica
Ian Brown has succeeded Daniel Green as CEO of BioCeramic Therapeutics (BCT), as the UK tissue regeneration products company enters its next stage of commercial growth. Mr Green, who has been at BCT since it was spun out of Imperial College, will remain as a board director. Mr Brown has held senior executive roles in both large multinationals and small- to medium-sized companies. His experience covers, among other things, M&A transactions and post-deal integration, fundraisings and IPOs. He joins London-based BCT as the firm is close to commercialising its first products, which include bioceramics for hard tissue treatment and flexible biomimetic scaffold for tissue engineering.